Skip to main content
. 2022 Jul 21;13(1):213–226. doi: 10.1016/j.apsb.2022.07.008

Figure 3.

Figure 3

Allosteric functional properties of pyrazol-4-yl-pyridine 813 at the hM4. (A) ACh-mediated [35S]-GTPγS accumulation binding curves in absence or presence of increasing concentrations of pyrazol-4-yl-pyridine compounds. (B) Efficacy cooperativity parameters and (C) efficacy parameters of pyrazol-4-yl-pyridine compounds obtained using the operational model of allosterism [Eq. (2)]. Values represent the mean ± SEM obtained from three experiments conducted in duplicate (total n = 6).